Screener / SEC EDGAR /CIK 0001773751 /10-K filed Feb 23, 2026, compared with Feb 24, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Offices & Clinics of Doctors of Medicine

Hims & Hers Health, Inc. HIMS

Compare with peers Embed
Insider trades since May 20, 2026

Insiders bought $1.2M and sold $9.7M on the market

Form 4
Bought on the market $1.2M 1 trade by 1 insider
Sold on the market $9.7M 23 trades by 7 insiders
Sold under a 10b5-1 plan 100% of the value sold, under a plan set up in advance
Traded the most Oluyemi Okupe $4.8M Chief Financial Officer

Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.

A year of insider trades, day by day

Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025

NovDecJanFebMarAprMayJunJulAugSepOctNov Mon Wed Fri

$1.2M bought on 1 day, $9.9M sold on 19 days. Each square is a day; click one for its Form 4.

SoldBought

Buys and sales by insider

Who traded · Form 4, added up

InsiderBoughtSoldLatest
Oluyemi Okupe
Chief Financial Officer
-$4.8M Oct 1, 2026
Soleil Boughton
Chief Legal Officer
-$1.3M Oct 28, 2026
David B. Wells
Director
$1.2M- May 26, 2026
Mohamed Elshenawy
CTO
-$1.2M Sep 15, 2026
Michael Chi
Chief Operating Officer
-$840K Sep 15, 2026
Patrick Harrison Carroll
Chief Medical Officer
-$830K Jun 18, 2026
Deborah M. Autor
Chief Policy Officer, Director
-$467K Aug 18, 2026
Irene Becklund
PAO
-$371K Jun 17, 2026

Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.

Trade by trade, newest first

Every trade · each date links to its Form 4

Of 23 open-market sales by officers and directors, 3 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Of 1 buy, 0. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.

DateInsiderTypeSharesValue
Oct 28, 2026 Soleil Boughton Sale (10b5-1) -3,462 96K
Oct 14, 2026 Soleil Boughton Sale (10b5-1) -3,461 101K
Oct 1, 2026 Oluyemi Okupe Sale (10b5-1) -2,000 59K
Sep 30, 2026 Soleil Boughton Sale (10b5-1) -3,461 101K
Sep 22, 2026 Oluyemi Okupe Sale (10b5-1) -29,277 877K
Sep 17, 2026 Oluyemi Okupe Sale (10b5-1) -12,313 355K
Sep 16, 2026 Soleil Boughton Sale (10b5-1) -6,236 174K
Sep 15, 2026 Michael Chi Sale (10b5-1) -14,027 398K
Sep 15, 2026 Mohamed Elshenawy Sale (10b5-1) -7,954 226K
Sep 2, 2026 Soleil Boughton Sale (10b5-1) -3,458 98K
Aug 19, 2026 Soleil Boughton Sale (10b5-1) -25,111 692K
Aug 19, 2026 Oluyemi Okupe Sale (10b5-1) -4,938 148K
Aug 18, 2026 Deborah M. Autor Sale (10b5-1) -16,773 467K
Aug 17, 2026 Oluyemi Okupe Sale (10b5-1) -9,388 262K
Jul 17, 2026 Oluyemi Okupe Sale (10b5-1) -7,163 229K
Jul 6, 2026 Oluyemi Okupe Sale (10b5-1) -7,163 261K
Jun 22, 2026 Oluyemi Okupe Sale (10b5-1) -18,197 619K
Jun 18, 2026 Patrick Harrison Carroll Sale (10b5-1) -23,726 830K
Jun 18, 2026 Oluyemi Okupe Sale (10b5-1) -55,383 1.9M
Jun 17, 2026 Mohamed Elshenawy Sale (10b5-1) -30,040 946K
Jun 17, 2026 Irene Becklund Sale (10b5-1) -4,490 141K
Jun 17, 2026 Michael Chi Sale (10b5-1) -14,027 442K
Jun 16, 2026 Irene Becklund Sale (10b5-1) -7,573 229K
May 26, 2026 David B. Wells Buy 48,400 1.2M
Show the other 9 trades

Sources

Form 4s from SEC's filing index. An insider files one within two business days of a trade.

Also

Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HIMS/export.csv") into a cell.

Next:Insider selling plans
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.